Cite

HARVARD Citation

    Honda, Y. et al. (2017). Clinical outcome and prognostic factors in hepatocellular carcinoma patients with bone metastases medicated with zoledronic acid. Hepatology research. 47 (10), pp. 1053-1060. [Online]. 
  
Back to record